首页> 外文会议>International Conference on Biosciences and Medical Engineering >The Role of Probiotics in Lowering Severity of Symptoms in Urban Women with Functional Constipation: A Randomized Double-Blind Controlled Trial
【24h】

The Role of Probiotics in Lowering Severity of Symptoms in Urban Women with Functional Constipation: A Randomized Double-Blind Controlled Trial

机译:益生菌在功能性便秘中降低城市妇女症状严重程度的作用:随机双盲对照试验

获取原文

摘要

Functional constipation is one of the most common gastrointestinal disorders worldwide, especially in women. Probiotic consumption is commonly used to alleviate symptoms of constipation but the mechanism and the result remain unclear. Hence, this study was conducted to assess the effect of probiotics on constipation symptoms using PAC-SYM? (Patient Assessment of Constipation Symptoms) questionnaire. This was a randomized double-blind controlled trial (RCT) study, consisting of 73 subjects of urban women with functional constipation. This study compared three weeks of probiotic (Lactobacillus plantarum IS 10506) administration with placebo and evaluated improvements in PAC-SYM? scores before and after intervention. The subjects were divided into two groups, probiotics group (n = 34) and placebo group (n = 39), then were compared for their mean difference of PAC-SYM? scores. Our study suggested improvements of symptoms after three weeks of probiotic administration, as shown by the total score of PAC-SYM? (mean difference 7.65, 95% CI 3.1-12.20; p=0.001) along with three domains of PAC-SYM?, abdominal symptoms (mean difference 3.0, 95% CI 1.3-4.7; p=0.001), rectal symptoms (mean difference 1.62, 95% CI 0.12-3.13; p=0.034) and stool symptoms (mean difference 3.02, 95% CI 0.58-5.45; p=0.016. Probiotics was superior than placebo in improvements of constipation symptoms in urban women with functional constipation.
机译:功能性便秘是全球最常见的胃肠道障碍之一,特别是女性。益生菌消费通常用于缓解便秘的症状,但机制和结果仍然不清楚。因此,本研究进行了评估益生菌对使用Pac-Sym的便秘症状的影响吗? (患者评估便秘症状)问卷。这是一项随机的双盲对照试验(RCT)研究,由具有功能性便秘的73名城市妇女组成。本研究百分之三周的益生菌(Lactobacillus Plantarum为10506)给予安慰剂,评价Pac-Sym的改善吗?在干预之前和之后得分。将受试者分为两组,益生菌组(n = 34)和安慰剂组(n = 39),然后比较它们的PAC-SYM的平均差异?得分。我们的研究表明益生菌给药三周后症状的改善,如pac-sym的总得分所示? (平均差异7.65,95%CI 3.1-12.20; p = 0.001)以及腹部症状的三个域(平均差异3.0,95%CI 1.3-4.7; p = 0.001),直肠症状(平均差异1.62,95%CI 0.12-3.13; p = 0.034)和粪便症状(平均差异3.02,95%CI 0.58-5.45; P = 0.016。益生菌优于安慰剂,改善了城市妇女的便秘症状,具有功能性便秘的便秘症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号